Atea director buys 6,100 shares in open market
Atea Pharmaceuticals director Polly A. Murphy reported an open-market purchase of 6,100 shares of Common Stock on May 18, 2026 at a weighted average price of $4.1715 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4/A
Rhea-AI Filing Summary
Atea Pharmaceuticals director Polly A. Murphy reported an open-market purchase of 6,100 shares of Common Stock on May 18, 2026 at a weighted average price of $4.1715 per share. Following this trade, she directly owns 92,145 shares of Atea Pharmaceuticals.
The shares were bought in multiple transactions at prices ranging from $4.14 to $4.19 per share. This Form 4/A amends a prior Form 4 only to correct the transaction date, which had been mistakenly reported as May 18, 2025 instead of May 18, 2026.
Insider Trade Summary
Net Buyer: 6,100 shares
Net Buy
1 txn
Insider
Murphy Polly A.
Role
Director
Bought
6,100 shs ($25K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 6,100 | $4.1715 | $25K |
Holdings After Transaction:
Common Stock — 92,145 shares (Direct)
Footnotes (2)
- F1. This Form 4/A has been filed solely to correct the date of the transaction reported in Column 2 of Table I of the Reporting Person's Form 4 filed on May 20, 2026, which was inadvertently noted as "May 18, 2025" instead of "May 18, 2026."
- F2. The price reported in Column 4 is a weighted average price. The securities were purchased in multiple transactions at prices ranging from $4.14 to $4.19 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Key Figures
Shares purchased: 6,100 shares
Weighted average price: $4.1715 per share
Post-transaction holdings: 92,145 shares
+2 more
5 metrics
Shares purchased
6,100 shares
Open-market purchase on May 18, 2026
Weighted average price
$4.1715 per share
Price paid for 6,100 shares
Post-transaction holdings
92,145 shares
Common Stock directly owned after purchase
Trade price range
$4.14–$4.19 per share
Range of individual trade prices within purchase
Net shares bought
6,100 shares
Net buy direction in transaction summary
Key Terms
Form 4/A, open-market purchase, weighted average price, Common Stock, +1 more
5 terms
Form 4/A regulatory
"This Form 4/A has been filed solely to correct the date of the transaction"
Form 4/A is an amended filing that corrects or updates an earlier Form 4, the mandatory report that insiders (like company executives, directors, or large shareholders) must file when their ownership stakes change. Think of it as an edited receipt showing who bought or sold stock and when; investors use it to track insider confidence, detect potential conflicts, and spot trading patterns that might signal future company prospects.
open-market purchase financial
"transaction_action: "open-market purchase""
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Common Stock financial
"security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
transaction code "P" regulatory
"transaction_code_description: "Purchase in open market or private transaction""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Atea Pharmaceuticals (AVIR) report for Polly A. Murphy?
Atea Pharmaceuticals director Polly A. Murphy reported buying 6,100 shares of Common Stock in an open-market transaction on May 18, 2026, at a weighted average price of $4.1715 per share, increasing her direct ownership to 92,145 shares.
Why was this Atea Pharmaceuticals (AVIR) Form 4/A filed as an amendment?
The Form 4/A was filed solely to correct the transaction date previously reported. The original Form 4 listed the purchase date as May 18, 2025, but the amendment clarifies the correct date was May 18, 2026 for the same 6,100-share transaction.
What type of transaction did Polly A. Murphy execute in Atea Pharmaceuticals (AVIR) stock?
The filing describes the trade as an open-market purchase of Atea Pharmaceuticals Common Stock. The transaction is coded as a “P” purchase, indicating shares were acquired in the market rather than through options exercises, gifts, or other non-market mechanisms.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates